XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025

Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025
The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY is traded cum capital adjustment on 14.03.2025 and ex capital adjustment on 17.03.2025

Das Instrument 6W5 FR0011464452 SPINEGUARD EO -,05 EQUITY wird ex Kapitalmassnahme gehandelt am 14.03.2025
The instrument 6W5 FR0011464452 SPINEGUARD EO -,05 EQUITY is traded ex capital adjustment on 14.03.2025

Das Instrument TM9 NO0010360019 NORAM DRILLING CO. NK 2 EQUITY wird ex Kapitalmassnahme gehandelt am 14.03.2025
The instrument TM9 NO0010360019 NORAM DRILLING CO. NK 2 EQUITY is traded ex capital adjustment on 14.03.2025

Das Instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025
The instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY is traded cum capital adjustment on 14.03.2025 and ex capital adjustment on 17.03.2025

Zeit	Aktuelle Nachrichten
14.03.	XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025	Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen
10.03.	Guard Therapeutics International AB: The Board of Directors of Guard Therapeutics has resolved on a previously announced rights issue of approximately SEK 150 million	THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen
27.02.	Guard Therapeutics International AB: Guard Therapeutics announces positive outcome from first independent safety data review in Phase 2b POINTER study	Guard Therapeutics announced today that an independent Data Safety Monitoring Committee (DSMC) has completed its first planned review of safety data and has recommended that the Phase 2b clinical study... ► Artikel lesen

Zeit

Aktuelle Nachrichten

14.03.

XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025

10.03.

Guard Therapeutics International AB: The Board of Directors of Guard Therapeutics has resolved on a previously announced rights issue of approximately SEK 150 million

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA...
► Artikel lesen

27.02.

Guard Therapeutics International AB: Guard Therapeutics announces positive outcome from first independent safety data review in Phase 2b POINTER study

Guard Therapeutics announced today that an independent Data Safety Monitoring Committee (DSMC) has completed its first planned review of safety data and has recommended that the Phase 2b clinical study...
► Artikel lesen

Zeit	Aktuelle Nachrichten
14.03.	NorAm Drilling AS - Ex cash distribution USD 0.04 today
14.03.	XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025	Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen
10.03.	NorAm Drilling AS - Monthly rig update and key information relating to the cash distribution for March 2025
28.02.	NorAm Drilling AS - PDMR Notification Following Option Exercise
28.02.	NorAm Drilling AS - Issue of New Shares Following Option Exercise

Zeit

Aktuelle Nachrichten

14.03.

NorAm Drilling AS - Ex cash distribution USD 0.04 today

14.03.

XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025

10.03.

NorAm Drilling AS - Monthly rig update and key information relating to the cash distribution for March 2025

28.02.

NorAm Drilling AS - PDMR Notification Following Option Exercise

28.02.

NorAm Drilling AS - Issue of New Shares Following Option Exercise

Zeit	Aktuelle Nachrichten
14.03.	XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025		Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen
13.03.	NGM MARKET NOTICE: #25-22 Rights issue in Obducat AB

Zeit

Aktuelle Nachrichten

14.03.

XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025

13.03.

NGM MARKET NOTICE: #25-22 Rights issue in Obducat AB

Zeit	Aktuelle Nachrichten
14.03.	XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025	Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen
10.02.	SpineGuard Announces the Commercial Launch of its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion	Innovation developed in partnership with the US company Omnia Medical Omnia launched PsiFGuard at the NANS convention in Orlando, from Jan. 30th to Feb. 1st, 2025 Regulatory News: SpineGuard... ► Artikel lesen
10.01.	SpineGuard Reports Its Full-Year 2024 Revenue	+8% growth globally, +20% in the US Regulatory News: SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology... ► Artikel lesen
07.01.	SpineGuard Completes a Bond Financing to Support the Deployment of Its New Products	Regulatory News: SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen
06.01.	SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership	Scope of initial agreement extended to other products and countries Reallocation of personnel and resources to bolster the launch of Omnia products in the United States including PsiFGuard Regulatory... ► Artikel lesen

Zeit

Aktuelle Nachrichten

14.03.

XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025

10.02.

SpineGuard Announces the Commercial Launch of its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion

Innovation developed in partnership with the US company Omnia Medical Omnia launched PsiFGuard at the NANS convention in Orlando, from Jan. 30th to Feb. 1st, 2025 Regulatory News: SpineGuard...
► Artikel lesen

10.01.

SpineGuard Reports Its Full-Year 2024 Revenue

+8% growth globally, +20% in the US Regulatory News: SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology...
► Artikel lesen

07.01.

SpineGuard Completes a Bond Financing to Support the Deployment of Its New Products

Regulatory News: SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement...
► Artikel lesen

06.01.

SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership

Scope of initial agreement extended to other products and countries Reallocation of personnel and resources to bolster the launch of Omnia products in the United States including PsiFGuard Regulatory...
► Artikel lesen